Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
526 Leser
Artikel bewerten:
(2)

Innovar Healthcare: The Market Has Spoken: BridgeLink Surpasses 10,000 Downloads, Solidifying Status as the Global Standard for Open-Source Health Interoperability

MONTGOMERY, AL / ACCESS Newswire / January 27, 2026 / Innovar Healthcare today announced that BridgeLink, the open-source integration engine, has surpassed 10,000 enterprise downloads, a milestone that signals a decisive shift in the healthcare IT landscape. Following the market shift toward restrictive proprietary licensing for the industry's legacy engine, the healthcare community has decisively moved to BridgeLink as the premier open-source replacement.

This rapid adoption-achieved in less than a year since its March 2025 launch-confirms that healthcare organizations are prioritizing strategic resilience and technical transparency over vendor lock-in. BridgeLink is no longer just an alternative; it has become the operational standard for hospitals, Digital Health, Health Information Exchanges (HIEs), and laboratories worldwide seeking to secure their interoperability infrastructure.

"The volume of downloads we are seeing represents a 'Great Migration' in health tech," said Loyd Bittle, CEO of Innovar Healthcare. "The market has spoken clearly: interoperability must remain open. By choosing BridgeLink, these 10,000+ users aren't just downloading software; they are voting for a future where they control their own data architecture without fear of forced commercial licensing or 'financial toxicity'."

Global Enterprise Validation

The platform's ascent is driven by major enterprise migrations across the US and Europe, validating BridgeLink's readiness for mission-critical, high-volume environments.

Maris Healthcare GmbH, a leader in the German healthcare market, is currently undertaking a massive infrastructure transition.

"We are currently migrating 105 servers from Mirth Connect to BridgeLink, a decision driven by the need for long-term stability and open-source flexibility. As an official reseller partner, we are seeing firsthand that the D-A-CH region demands a solution that guarantees data sovereignty. BridgeLink is that solution."

- Jochen Fuchs, Managing Director, MARIS Healthcare GmbH

In the United States, HealtheConnections, a regional Health Information Exchange (HIE) supporting hundreds of millions of patient records, selected BridgeLink to ensure uninterrupted data exchange for its provider network.

"As an HIE, we're directly supporting patient care and cannot afford downtime or uncertainty. Innovar's expertise and the BridgeLink platform provided us with a seamless migration path that kept our data flowing securely."

- Brad Hesler, VP of Technology Services, HealtheConnections

Innovation Over Maintenance

While legacy options stagnate, BridgeLink has delivered rapid technical advancements. The platform has introduced the Dynamic Lookup Gateway (DLG) for high-speed context-aware routing and Message Trends for volume visualization. Additionally, BridgeLink has integrated Git-based Channel History directly into the open-source core while addressing enterprise security needs with advanced Multi-Factor Authentication (MFA) capabilities.

Innovar Healthcare remains the primary custodian of the project, providing the specialized consulting and "real expertise" required to solve the "last mile" interoperability challenges that organizations face during this transition.

For more information or to download BridgeLink, visit https://www.innovarhealthcare.com/bridgelink-10k

About Innovar Healthcare

Innovar Healthcare is the leading provider of healthcare interoperability solutions and the primary steward of the BridgeLink initiative. Specializing in high-complexity data integration for HIEs, labs, and digital health companies, Innovar is dedicated to preserving open access to the technology that powers global patient data exchange.

Media Contact:

Kate Lunt
Chief Marketing Officer
marketing@innovarhealthcare.com

SOURCE: Innovar Healthcare



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/the-market-has-spoken-bridgelink-surpasses-10-000-downloads-solid-1130934

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.